Literature DB >> 9454332

Extension of life-span by introduction of telomerase into normal human cells.

A G Bodnar1, M Ouellette, M Frolkis, S E Holt, C P Chiu, G B Morin, C B Harley, J W Shay, S Lichtsteiner, W E Wright.   

Abstract

Normal human cells undergo a finite number of cell divisions and ultimately enter a nondividing state called replicative senescence. It has been proposed that telomere shortening is the molecular clock that triggers senescence. To test this hypothesis, two telomerase-negative normal human cell types, retinal pigment epithelial cells and foreskin fibroblasts, were transfected with vectors encoding the human telomerase catalytic subunit. In contrast to telomerase-negative control clones, which exhibited telomere shortening and senescence, telomerase-expressing clones had elongated telomeres, divided vigorously, and showed reduced straining for beta-galactosidase, a biomarker for senescence. Notably, the telomerase-expressing clones have a normal karyotype and have already exceeded their normal life-span by at least 20 doublings, thus establishing a causal relationship between telomere shortening and in vitro cellular senescence. The ability to maintain normal human cells in a phenotypically youthful state could have important applications in research and medicine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454332     DOI: 10.1126/science.279.5349.349

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  1245 in total

1.  Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1.

Authors:  R M Alani; J Hasskarl; M Grace; M C Hernandez; M A Israel; K Münger
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  TIN2, a new regulator of telomere length in human cells.

Authors:  S H Kim; P Kaminker; J Campisi
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

3.  The length of telomeric G-rich strand 3'-overhang measured by oligonucleotide ligation assay.

Authors:  G Cimino-Reale; E Pascale; E Battiloro; G Starace; R Verna; E D'Ambrosio
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

Review 4.  Replacement of damaged neural cells: a mirage?

Authors:  S Eridani
Journal:  J R Soc Med       Date:  1999-10       Impact factor: 5.344

5.  The coevolution of cell senescence and diploid sexual reproduction in unicellular organisms.

Authors:  Y Cui; R S Chen; W H Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

6.  Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage.

Authors:  K Webley; J A Bond; C J Jones; J P Blaydes; A Craig; T Hupp; D Wynford-Thomas
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 7.  Cellular and molecular mechanisms of aging and age related diseases.

Authors:  R Ladislas
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

8.  The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function.

Authors:  W Fu; M Killen; C Culmsee; S Dhar; T K Pandita; M P Mattson
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

9.  Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA.

Authors:  H Niida; Y Shinkai; M P Hande; T Matsumoto; S Takehara; M Tachibana; M Oshimura; P M Lansdorp; Y Furuichi
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

10.  Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.

Authors:  R V Lord; D Salonga; K D Danenberg; J H Peters; T R DeMeester; J M Park; J Johansson; K A Skinner; P Chandrasoma; S R DeMeester; C G Bremner; P I Tsai; P V Danenberg
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.